Management of Croup Patients After Decadron Administration in the Emergency Room

Discharge Recommendations for Croup

Patients with croup should be discharged only when symptoms have stabilized, as recommended by the American Thoracic Society, to ensure adequate recovery and reduce return visits 1
Parents should be instructed to return if stridor at rest returns or worsens, as this indicates potential worsening of croup symptoms, according to the American Academy of Pediatrics 2
Follow-up with primary care provider within one week of discharge is crucial for monitoring the patient's condition and adjusting treatment as needed, as suggested by the American College of Emergency Physicians 3

Significant clinical improvement after dexamethasone administration, including no stridor at rest and minimal or no respiratory distress, indicates that the patient is safe for discharge, as per the guidelines from the American Academy of Pediatrics 2
Persistent moderate to severe respiratory distress despite treatment is an indication for admission, as recommended by the American Thoracic Society, to ensure close monitoring and adequate care 2
Inability of parents to recognize worsening symptoms is a social concern that warrants admission, as it may compromise the patient's safety and outcome, according to the American College of Emergency Physicians 1

Discharging patients too early before adequate observation period after treatment can lead to poor outcomes and increased return visits, as warned by the American Academy of Pediatrics 3
Failing to provide clear return precautions to parents can result in delayed recognition of worsening symptoms and compromised patient care, as emphasized by the American College of Emergency Physicians 1

Patients who require more than 2 doses of racemic epinephrine have admission rates exceeding 80%, according to the American Academy of Pediatrics, and should be considered for hospital admission 4, 5
The American Academy of Pediatrics suggests that patients receiving ≤2 doses of racemic epinephrine can be safely discharged with admission rates as low as 1.7%, indicating a low risk of complications 4, 5